News

7th Genomics, Neuroscience, Therapeutics and Data Innovation Summit (GeNeDis) - 19–22 November 2026 Stavros Niarchos Foundation Cultural Center

ShareThis
Posted: 05-11-2026 12:04 | Views: 1092
Start: 19-11-2026 |End: 22-11-2026
[Forthcoming]
image

The Bioinformatics and Human Electrophysiology Laboratory (BiHELab) of the Department of Informatics at the Ionian University is organizing the 7th International GeNeDis Conference (Genomics, Neuroscience, Therapeutics and Data Innovation Summit), which will take place from 19 to 22 November 2026 at the Stavros Niarchos Foundation Cultural Center (SNFCC) in Athens.

The conference will be held in a hybrid format, offering both in-person and online participation, under the auspices of H.E. the President of the Hellenic Republic, Mr Konstantinos A. Tasoulas. The Chair of the conference’s Scientific Committee is Professor Panayiotis Vlamos, Scientific Director of BiHELab.

The scientific programme focuses on computational neuroscience, genomics, and biomedical research, with particular emphasis on Alzheimer’s disease and other neurodegenerative disorders. The sessions will cover, among other topics, applications of artificial intelligence in biomedical data analysis and the development of new diagnostic approaches.

More than 200 scientific papers were submitted to GeNeDis 2026. This year’s conference will bring together more than 50 invited speakers from Greece and abroad, as well as 11 faculty members from the Ionian University.

Those interested can find information about the sessions and register for in-person or online participation through the conference’s official website.

Website: https://2026.genedis.org/

Programme: https://2026.genedis.org/program/conference-program/

Speakers: https://2026.genedis.org/program/keynote-and-invited-speakers/

Registration: https://2026.genedis.org/register-2/

Contact: info@genedis.org

 


Back
«Bioinformatics and Human Electrophysiology Lab»
The Bioinformatics and Human Electrophysiology Lab focuses on recent advances in geriatrics and neurodegeneration, ranging from basic science to clinical and pharmaceutical developments.
Text To SpeechText To Speech Text ReadabilityText Readability Color ContrastColor Contrast
Accessibility Options